Novartis granted orphan status for treatment of diffuse large B-cell lymphoma Novartis' Afinitor was granted FDA orphan designation as a treatment of diffuse large B-cell lymphoma, according to a post to the regulator's website. Reference Link
News For NVS From The Last 14 Days
Check below for free stories on NVS the last two weeks.
Novartis treatment for pigmented villonodular synovitis gets orphan designation According to a post on the FDA's website, Novartis' recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor received orphan designation. Reference Link